Literature DB >> 7441826

Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.

G Johansson, U Backman, B G Danielson, B Fellström, S Ljunghall, B Wikström.   

Abstract

Prophylactic treatment with magnesium hydroxide ws instituted in 56 consecutive cases with renal calcium stones. The patients had been investigated previously with regard to the magnesium metabolism. The urinary magnesium excretion increased promptly and remained on a higher level during treatment. No changes were observed in the serum or urinary calcium concentrations. Most patients have undergone treatment for at least 2 years and 45 have been free of recurrences of formations of new stones. The mean stone episode rate during treatment was 0.03 stones per year compared to 0.8 stones per year before treatment was instituted. The natural history of stone disease also was followed in 34 patients with stones who had received no prophylactic therapy and 15 have experienced recurrences after 2 years. Therefore, in comparison, treatment with magnesium hydroxide appeared to reduce the recurrence rate. Apart from minor gastrointestinal discomfort no adverse effects were observed during treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441826     DOI: 10.1016/s0022-5347(17)55655-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

Review 2.  Epidemiology of stone disease.

Authors:  Gary C Curhan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

3.  Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients.

Authors:  Irfan H Atakan; Mustafa Kaplan; Gulay Seren; Tevfik Aktoz; Hatice Gül; Osman Inci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

4.  Effects of dietary calcium, magnesium and phosphorus on the formation of struvite stones in the urinary tract of rats.

Authors:  H Takeuchi; M Ueda; M Satoh; O Yoshida
Journal:  Urol Res       Date:  1991

5.  Cross-sectional study of kidney stones by laser-induced breakdown spectroscopy.

Authors:  V K Singh; A K Rai; P K Rai; P K Jindal
Journal:  Lasers Med Sci       Date:  2008-12-23       Impact factor: 3.161

Review 6.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 7.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

8.  Treatment of Idiopathic calcium stone disease.

Authors:  B G Danielson; C Y Pak; L H Smith; W Vahlensieck; W G Robertson
Journal:  Calcif Tissue Int       Date:  1983-09       Impact factor: 4.333

9.  Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.

Authors:  Vivek K Singh; Pradeep K Rai
Journal:  Biophys Rev       Date:  2014-07-31

10.  Development of metaphylaxis in calcium urolithiasis: a restriction of conventional drug therapy.

Authors:  R Kocvara; G Louzenský; J Tuíková
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.